Literature DB >> 17266589

Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations.

P Mallia1, M Contoli, G Caramori, A Pandit, S L Johnston, A Papi.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are the 2 most prevalent chronic airway diseases. Much of the morbidity, mortality and health care costs of the diseases are associated with acute exacerbations, which are episodes of increased symptoms and airflow obstruction. Over the last decade evidence has emerged implicating virus respiratory tract infections as a major cause of exacerbations of both asthma and COPD. Current therapies are not very effective in the prevention or treatment of virus-induced exacerbations and exacerbations are therefore a major unmet medical need. The development of new and novel treatments requires a better understanding of the molecular and cellular mechanisms linking virus infection with exacerbations of asthma and COPD. This article provides an overview of current knowledge regarding the mechanisms of virus-induced exacerbations in both asthma and COPD. It will also review existing treatments and future treatments that are in advanced stages of development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266589     DOI: 10.2174/138161207779313777

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  25 in total

1.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

Review 2.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 3.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 4.  Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.

Authors:  Chun Geun Lee; Bing Ma; Seyedtaghi Takyar; Farida Ahangari; Charles Delacruz; Chuan Hua He; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2011-11

5.  Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections.

Authors:  Angus M MacLeod; Dale R Mitchell; Nicholas J Palmer; Hervé Van de Poël; Katja Conrath; Martin Andrews; Pieter Leyssen; Johan Neyts
Journal:  ACS Med Chem Lett       Date:  2013-05-08       Impact factor: 4.345

Review 6.  Host-microorganism interactions in lung diseases.

Authors:  Benjamin J Marsland; Eva S Gollwitzer
Journal:  Nat Rev Immunol       Date:  2014-12       Impact factor: 53.106

Review 7.  Differential assessment and management of asthma vs chronic obstructive pulmonary disease.

Authors:  Barbara P Yawn
Journal:  Medscape J Med       Date:  2009-01-21

8.  Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells.

Authors:  Alberto Papi; Marco Contoli; Pierluigi Gasparini; Laura Bristot; Michael R Edwards; Milvia Chicca; Marilena Leis; Adalberto Ciaccia; Gaetano Caramori; Sebastian L Johnston; Silvano Pinamonti
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

9.  Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors.

Authors:  Angelica Brandelius; Irma Mahmutovic Persson; Jenny Calvén; Leif Bjermer; Carl G A Persson; Morgan Andersson; Lena Uller
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 10.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.